Healthtech platform Oladoc raises $1.8 million in Pre-Series A round

Oladoc is a digital healthcare platform that connects patients with healthcare providers and health services.

2 mins read

Oladoc, a doctor booking and teleconsultation platform, has raised $1.8 million as part of its Pre-Series A round, led by Sarmayacar Ventures along with participation from Doha Tech Angels and other angel investors. The round was closed in 2021, however, the official confirmation has been made today, according to the company. 

Founded in 2016 by brothers Abid and Arif Zuberi, Oladoc is a doctor booking platform with a network of 8,000 doctors spread across 10 cities. It allows patients to search, book, rate, and review healthcare providers. In addition, the platform also provides its users the ability to order lab tests as well as saving their medical history in the application. 

As per a press statement, Oladoc has served more than 15 million users in the last 3 years and currently has more than 300,000 verified patient reviews online. 

Speaking on the raise, Abid Zuberi said, “Oladoc is on a mission to empower patients by making healthcare accessible, transparent, and affordable for the masses.  We have seen phenomenal growth in the last 12 months and with the fresh funding round, aim to evolve into a digital health mall that serves patients’ needs across the complete lifecycle. Oladoc plans to scale its current value proposition along with bringing in seasoned C-level leadership to the team, to help scale the organization faster.”

Rabeel Warraich, the founder and CEO at Sarmayacar, said, “We are excited to partner with Oladoc on their journey to provide quality healthcare to everyone in Pakistan. Oladoc’s team has demonstrated strong on-the-ground execution, helping establish oladoc as the No.1 Doctor booking platform in Pakistan. We look forward to working with the founders to accelerate Oladoc’s growth and unlock the full market potential.”

Data Darbar

Decoding Pakistan's Tech Sector

Leave a Reply

Your email address will not be published.

Follow Us